Research, Product Development, and the Work of the Task Forces

  • Richard Brooks


The original ‘product’ of the EQ Group’s efforts was the EuroQol instrument which was designated ‘EQ-5D’ in the mid-1990s. The formal incorporation of the EuroQol Foundation, and the establishment of the Business Management also took place at that time. With this structure in place the possibility to license the instrument arose and some finance was raised. Meanwhile the EQ-5D instrument remained unchanged, leaving the Group with just one ‘product’, with the exception of new language versions of the instrument. As more finances became available the potential to fund research projects and to develop adapted or new EQ-5D products increased. The work of the task forces – the Youth TF (YTF), the Digital TF (DTF), the Condition Specific TF (CSPTF), and the Population Health TF (PHTF) – is detailed to help report upon the more recent developments in the work of the Group.


Population Health Task Force Executive Committee Child Version EuroQol Group 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Arons A and Krabbe P. Considering cognition as a bolt-on dimension for the EQ-5D. Paper presented at the 28th Scientific Plenary Meeting of the EuroQol Group, Oxford, September 2011.Google Scholar
  2. Badia X, Roset M, Perulero N. Validation of the EQ-5D to be used in children with persistent asthma. In Pickard (2004).Google Scholar
  3. Brooks R, Rabin R, de Charro F. The Measurement and Valuation of Health Status using EQ-5D: A European Perspective. Kluwer. 2003.Google Scholar
  4. Gusi N, Ortega Y, García-Martin Y, Monge M. Physical activity, lifestyle and health-related quality of life of secondary students in Extremadura, Spain. In Norinder et al (2002).Google Scholar
  5. Hennessy S and Kind P. Measuring health status in children: developing and testing a child-friendly version of EQ-5D. In Kind and Macran (2002).Google Scholar
  6. Jelsma J and Matyida N. The development of an adapted version of the EQ-5D for infants under the age of 36 months. In Prevolnik Rupel (2003).Google Scholar
  7. Jelsma J and Ferguson G. The determinants of HRQoL in able-bodied and disabled children. In de Pouvourville (2009).Google Scholar
  8. Klose, K and Greiner W.: Developing a cognitive dimension as a bolt-on for the EQ-5D-Y in Germany. Poster presented at the 28th Scientific Plenary Meeting, Oxford, UK, September 2011.Google Scholar
  9. Krabbe P, Stouthard M, Esssink-Bot M-L, Bonsel G. The effect of adding a cognitive dimension to the EuroQol multi-attribute health status classification system. Journal of Clinical Epidemiology 1999; 52:293–301.PubMedCrossRefGoogle Scholar
  10. PJB Publications. SCRIP’s 2000 pharmaceutical companies league tables. PJB Publications 2000.Google Scholar
  11. Ravens-Sieberer U, Wille N, Badia X, Bonsel G, Burström K, Cavrini G, Devlin N, Egmar A-C, Gusi N, Herdman M, Jelsma J, Kind P, Olivares P, Scalone L, Greiner W. Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study. Quality of Life Research 2010; 19:887–97.PubMedCrossRefGoogle Scholar
  12. Roset M, Badia X, Benavides A, Herdman M. The validity of the EQ-5D in children with asthma. In Badia et al (2000).Google Scholar
  13. Secnik K, Matza L, Mannix S, Sallee F. Use of the EQ-5D proxy version in a sample of parents who have children diagnosed with attention deficit/ hyperactivity disorder (ADHD). In Prevolnik Rupel (2003).Google Scholar
  14. Secnik, K, Matza, L, Mannix, S.The proxy EQ-5D as a quality of life measure in UK children with attention deficit/ hyperactivity disorder. In Pickard (2004).Google Scholar
  15. Selai C, Gaminde I, Herdman M, Johnson J, Rabin R. EQ-5D: modes of administration. In Brooks et al (2003).Google Scholar
  16. Solem C, Gu N, Pickard AS. Predicting VAS scores by EQ-5D Items and presence of disease: a bolt-on feasibility study. Paper presented at the 28th Scientific Plenary meeting of the EuroQol Group, Oxford, September 2011.Google Scholar
  17. Stavem K. (Ed.) 22nd Plenary Meeting of the EuroQol Group Discussion Papers, Oslo, Norway, September 2005. Helse-Øst Health Services Research Centre, Lørenskog, 2005.Google Scholar
  18. Wille N, Badia X, Bonsel G, Burström K, Cavrini G, Devlin N, Egmar A-C, Greiner W, Gusi N, Herdman M, Jelsma J, Kind P, Scalone L, Ravens-Sieberer U. Development of the EQ-5D-Y: a child-friendly version of the EQ-5D. Quality of Life Research 2010; 19:887–97.PubMedCrossRefGoogle Scholar
  19. Wille N, Hale S, Ravens-Sieberer U, Kohlmann T, Greiner W. Feasibility and preliminary validity of a German EQ-5D childrens version. In Stavem (2005).Google Scholar
  20. Wille N, Ravens-Sieberer U. and the child-friendly task force on behalf of the EuroQol Group. Establishing definitions of the concepts included in CF-EQ-5D: A revision of the “Definition of EQ-5D concepts” for adults. In Badia (2007).Google Scholar
  21. Yang Y et al. The effect of adding a ‘sleep’ dimension to EQ-5D. Paper given at the Health Economists’ Study Group Meeting, January 2008.Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2012

Authors and Affiliations

  • Richard Brooks
    • 1
  1. 1.EuroQol GroupRotterdamThe Netherlands

Personalised recommendations